The Returns On Capital At Shandong Teamgene Technology (SHSE:603151) Don't Inspire Confidence

Simply Wall St · 10/16 01:21

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key financial metrics. Typically, we'll want to notice a trend of growing return on capital employed (ROCE) and alongside that, an expanding base of capital employed. Put simply, these types of businesses are compounding machines, meaning they are continually reinvesting their earnings at ever-higher rates of return. However, after investigating Shandong Teamgene Technology (SHSE:603151), we don't think it's current trends fit the mold of a multi-bagger.

What Is Return On Capital Employed (ROCE)?

For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. The formula for this calculation on Shandong Teamgene Technology is:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.052 = CN¥66m ÷ (CN¥1.6b - CN¥310m) (Based on the trailing twelve months to June 2024).

So, Shandong Teamgene Technology has an ROCE of 5.2%. In absolute terms, that's a low return and it also under-performs the Food industry average of 7.2%.

Check out our latest analysis for Shandong Teamgene Technology

roce
SHSE:603151 Return on Capital Employed October 16th 2024

Above you can see how the current ROCE for Shandong Teamgene Technology compares to its prior returns on capital, but there's only so much you can tell from the past. If you'd like, you can check out the forecasts from the analysts covering Shandong Teamgene Technology for free.

So How Is Shandong Teamgene Technology's ROCE Trending?

When we looked at the ROCE trend at Shandong Teamgene Technology, we didn't gain much confidence. Over the last five years, returns on capital have decreased to 5.2% from 35% five years ago. Meanwhile, the business is utilizing more capital but this hasn't moved the needle much in terms of sales in the past 12 months, so this could reflect longer term investments. It's worth keeping an eye on the company's earnings from here on to see if these investments do end up contributing to the bottom line.

On a related note, Shandong Teamgene Technology has decreased its current liabilities to 20% of total assets. That could partly explain why the ROCE has dropped. Effectively this means their suppliers or short-term creditors are funding less of the business, which reduces some elements of risk. Since the business is basically funding more of its operations with it's own money, you could argue this has made the business less efficient at generating ROCE.

In Conclusion...

Bringing it all together, while we're somewhat encouraged by Shandong Teamgene Technology's reinvestment in its own business, we're aware that returns are shrinking. And in the last year, the stock has given away 33% so the market doesn't look too hopeful on these trends strengthening any time soon. In any case, the stock doesn't have these traits of a multi-bagger discussed above, so if that's what you're looking for, we think you'd have more luck elsewhere.

On a final note, we found 3 warning signs for Shandong Teamgene Technology (1 is concerning) you should be aware of.

While Shandong Teamgene Technology may not currently earn the highest returns, we've compiled a list of companies that currently earn more than 25% return on equity. Check out this free list here.